Treatment of intracellular Mycobacterium avium complex infection by free and liposome-encapsulated sparfloxacin - Wikidata - wikimedia - TriplyDB

Treatment of intracellular Mycobacterium avium complex infection by free and liposome-encapsulated sparfloxacin

Treatment of intracellular Mycobacterium avium complex infection by free and liposome-encapsulated sparfloxacin

http://www.wikidata.org/entity/Q28379298

about

Improved efficacy of ciprofloxacin administered in polyethylene glycol-coated liposomes for treatment of Klebsiella pneumoniae pneumonia in rats.Nanotechnology-Based Approach in Tuberculosis Treatment.

P2860

Q33982098-E3028A5F-EF2F-4CE0-A173-B82250979ADB Q37624974-A78911AC-D183-4AE2-A866-1B8F69185DC9

P2860

Treatment of intracellular Mycobacterium avium complex infection by free and liposome-encapsulated sparfloxacin

http://www.wikidata.org/entity/Q28379298

description

1996 nî lūn-bûn

@nan

1996 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

1996 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

1996年の論文

@ja

1996年論文

@yue

1996年論文

@zh-hant

1996年論文

@zh-hk

1996年論文

@zh-mo

1996年論文

@zh-tw

1996年论文

@wuu

name

Treatment of intracellular Myc ...... some-encapsulated sparfloxacin

@ast

Treatment of intracellular Myc ...... some-encapsulated sparfloxacin

@en

Treatment of intracellular Myc ...... some-encapsulated sparfloxacin

@nl

type

label

Treatment of intracellular Myc ...... some-encapsulated sparfloxacin

@ast

Treatment of intracellular Myc ...... some-encapsulated sparfloxacin

@en

Treatment of intracellular Myc ...... some-encapsulated sparfloxacin

@nl

prefLabel

Treatment of intracellular Myc ...... some-encapsulated sparfloxacin

@ast

Treatment of intracellular Myc ...... some-encapsulated sparfloxacin

@en

Treatment of intracellular Myc ...... some-encapsulated sparfloxacin

@nl

P1433

Q28379298-0C55232A-7B3F-4B56-AF92-680A5AE31E41

P1476

Q28379298-45BCC724-FCAA-4DF0-AC66-130E4785DF2E

P2093

Q28379298-0C089CB1-8D92-49FF-BAD6-9332626FAE98

Q28379298-27E28210-B1DC-40E1-A276-553449148BF9

Q28379298-30EF14D3-BFDE-4702-BE00-1CD3CF86F917

Q28379298-9E4553DF-20C1-4D7F-8B08-F6208E9976DC

Q28379298-BCA61084-F45A-46F7-B8FC-BB7660ACE38A

P2860

Q28379298-0990DAA9-52FF-49D4-8743-3D647A1954B6

Q28379298-0AE77877-5326-426A-9845-BC0D10AEC16B

Q28379298-0F493C39-B164-4A5A-B8BC-5A58EAF00989

Q28379298-1222C8E2-2898-4426-BA78-9D7D838136E3

Q28379298-18546485-7EC0-44FF-8DA1-C12620EE57DE

Q28379298-189DD673-13BE-4EE0-80ED-6534CFD00327

Q28379298-29278E2B-AE86-4430-83C6-8BA73ABFEB2B

Q28379298-30CED930-6C1B-45BB-AEFA-B0AF620273AC

Q28379298-3537E4C1-F235-4801-855F-B38DCB7BD435

Q28379298-35E6CD12-E660-4462-92E0-DFAD7B7F12FD

P304

Q28379298-AB27C128-A1DD-4268-9FB1-858599F666F3

P31

Q28379298-D9EFFA23-73AF-473B-929B-F07D1D350756

P356

Q28379298-A3753AF6-FAD3-41AE-8F08-61295E82EDAA

P407

Q28379298-83E59403-E728-49A2-815F-8427047F0ACE

P433

Q28379298-AC3935CD-04DB-4E80-A78B-2B0ACA3C230A

P478

Q28379298-973FA196-BBDD-41F1-945E-28859657CE80

P577

Q28379298-ABF16C5C-9A57-4FBB-AFE6-16ACABFB4B3E

P698

Q28379298-93CE6C93-8829-492E-A072-B57702414294

P932

Q28379298-E244C3BD-C67C-4745-9BE4-A583D6703390

P356

P1433

Antimicrobial Agents and Chemotherapy

P1476

Treatment of intracellular Myc ...... some-encapsulated sparfloxacin

@en

P2093

D Flasher

http://www.w3.org/2001/XMLSchema#string

J Luna-Herrera

http://www.w3.org/2001/XMLSchema#string

M V Reddy

http://www.w3.org/2001/XMLSchema#string

N Düzgüneş

http://www.w3.org/2001/XMLSchema#string

P R Gangadharam

http://www.w3.org/2001/XMLSchema#string

P2860

Mycobacterium avium complex infection in the acquired immunodeficiency syndrome

Activities of sparfloxacin, azithromycin, temafloxacin, and rifapentine compared with that of clarithromycin against multiplication of Mycobacterium avium complex within human macrophages

Antimycobacterial spectrum of sparfloxacin and its activities alone and in association with other drugs against Mycobacterium avium complex growing extracellularly and intracellularly in murine and human macrophages

In vitro susceptibility of Mycobacterium avium complex to the new fluoroquinolone sparfloxacin (CI-978; AT-4140) and comparison with ciprofloxacin

Therapeutic efficacy of liposome-encapsulated kanamycin against Mycobacterium intracellulare infection induced in mice

Chemotherapeutic potential of free and liposome encapsulated streptomycin against experimental Mycobacterium avium complex infections in beige mice

Liposome-encapsulated-gentamicin therapy of Mycobacterium avium complex infection in beige mice

Enhanced effect of liposome-encapsulated amikacin on Mycobacterium avium-M. intracellulare complex infection in beige mice

In vitro activities of free and liposomal drugs against Mycobacterium avium-M. intracellulare complex and M. tuberculosis

Anti-Mycobacterium avium activity of quinolones: in vitro activities

P304

2618-2621

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/AAC.40.11.2618

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

40

http://www.w3.org/2001/XMLSchema#string

P577

1996-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

8913475

http://www.w3.org/2001/XMLSchema#string

P932

163586

http://www.w3.org/2001/XMLSchema#string